Cell & Gene Therapies

Pic:getty/andrewbrookes

Resilience and Harvard University launch five year R&D alliance

By Rachel Arthur

The new alliance will focus on the development and manufacturing of complex medicines including biologics, vaccines, nucleic acids and cell and gene therapies; as well as looking to launch companies to advance the manufacture of such medicines.

© GettyImages/John M Lund Photography Inc

Marken to add Kenya and Ghana to GMP storage network

By Jane Byrne

Marken, the clinical trial logistics subsidiary of UPS Healthcare, is adding significant capacity to support increased demand for its clinical drug supply chain services, particularly for cell and gene clinical trials.

Follow us

Products

View more

Webinars